Cargando…
Single‐domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors
Novel therapies for hemophilia, including non‐factor replacement and in vivo gene therapy, are showing promising results in the clinic, including for patients having a history of inhibitor development. Here, we propose a novel therapeutic approach for hemophilia based on llama‐derived single‐domain...
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136963/ https://www.ncbi.nlm.nih.gov/pubmed/32159286 http://dx.doi.org/10.15252/emmm.201911298 |